Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06672510 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)
A NA study of Pulmonary Embolism Acute, sponsored by Akura Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 118
- Enrollment target
- 12
- Study locations
NCT06672510: Recruiting NA study of Pulmonary Embolism Acute, sponsored by Akura Medical.
NCT06672510 is a NA study of Pulmonary Embolism Acute that is actively recruiting participants, run by Akura Medical. The registered enrollment target is 118 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 12 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06672510, a NA study of Pulmonary Embolism Acute, is actively recruiting participants, sponsored by Akura Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
- 12
- Study locations
Study Summary
This study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the Akura Thrombectomy System in subjects with acute pulmonary embolism (PE).
Conditions Studied
Interventions
- DEVICE ATC
Study Locations (12)
Florida
- Manatee Hospital / Nova Clinical Research Center - Bradenton
- Jacksonville Memorial (HCA) - Jacksonville
- Tallahasse Memorial Hospital - Tallahassee
New York
- Columbia University Medical Center - New York
- Cumc/Nyph - New York
California
- Los Robles Regional Medical Center - Thousand Oaks
Colorado
- Advanced Heart & Vein (ClinRe-001-001) - Thornton
Connecticut
- Hartford Healthcare - Hartford
Minnesota
- Centracare Heart & Vascular Center - Saint Cloud
Ohio
- ProMedica Toledo Hospital - Toledo
Tennessee
- Tristar Centennial Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06672510 shows while recruiting
NCT06672510 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Pulmonary Embolism Acute appearing as the primary indexed condition, and to 1 intervention - of which ATC is the first listed.
NCT06672510 lists 12 locations in 9 states (Florida, New York, California).
Frequently Asked Questions
What is clinical trial NCT06672510 about?
NCT06672510 is a clinical study titled "Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)". This study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the Akura Thrombectomy System in subjects with acute pulmonary embolism (PE).
What is the current status of trial NCT06672510?
This trial is currently recruiting. It is a NA study. The enrollment target is 118 participants. The study started on 2025-01-01. Estimated completion is 2026-12.
What conditions does trial NCT06672510 study?
This clinical trial studies the following conditions: Pulmonary Embolism Acute.
What interventions are being tested in trial NCT06672510?
The interventions under investigation include: ATC (DEVICE).
Who is sponsoring clinical trial NCT06672510?
This trial is sponsored by Akura Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06672510 being conducted?
This trial has 12 study locations across California, Colorado, Connecticut, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06672510's enrollment target sits among peer trials
118 803rd of 2000 higher than 1,194 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI